Call Us Today to Make an Appointment. 1.800.734.2210

Testosterone and Reduction in Cardiovascular Risk

April 12, 2011 by  
Filed under Testosterone - Men

Researchers writing in the European Journal of Endocrinology say that “Testosterone replacement therapy reduces insulin resistance and improves glycaemic control in hypogonadal men with type 2 diabetes. Improvements in glycaemic control, insulin resistance, cholesterol and visceral adiposity together represent an overall reduction in cardiovascular risk.”

Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006 Jun;154(6):899-906.

Written by Dr. Marc Darrow, M.D.

Dr. Darrow is a world recognized specialist in many chronic disorders. He has been featured in national publications, and television and radio shows, for his innovative approach to medicine. As the medical director of the Darrow Wellness Institute in West Los Angeles, Dr. Darrow has helped create an age management program for those individuals interested in maintaining a youthful, healthy vigor for adults through “middle age” and well into the senior years.

Comments are closed.

Prolotherapy, PRP, AGE MANAGEMENT MEDICINE, and other modalities mentioned are medical techniques that may not be considered mainstream. As with any medical TREATMENT, results will vary among individuals, and there is no implication that you will HEAL OR receive the same outcome as patients herein. there could be pain or substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.
THE INFORMATION IN THIS WEBSITE IS OFFERED FOR EDUCATIONAL PURPOSED ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. THE PHOTOS USED MAY BE MODELS AND NOT PATIENTS.